| scholarly article | Q13442814 |
| P2093 | author name string | Chen Chang | |
| Chiao-Chi V Chen | |||
| Tiing Yee Siow | |||
| Kai-Ping N Chow | |||
| Nina Wan | |||
| P2860 | cites work | Cyclic guanosine monophosphate as a mediator of vasodilation | Q24623087 |
| Nitric oxide: physiology, pathophysiology, and pharmacology | Q26778243 | ||
| 1-Methyl-4-phenylpyridinium ion (MPP+): Identification of a metabolite of MPTP, a toxin selective to the substantia nigra | Q28266104 | ||
| Reduction of MPP(+)-induced hydroxyl radical formation and nigrostriatal MPTP toxicity by inhibiting nitric oxide synthase. | Q30463956 | ||
| Quantitative measurements of cerebral blood flow in rats using the FAIR technique: correlation with previous iodoantipyrine autoradiographic studies | Q32067923 | ||
| Multi-slice perfusion-based functional MRI using the FAIR technique: comparison of CBF and BOLD effects | Q32145298 | ||
| Pharmacological MRI in animal models: a useful tool for 5-HT research? | Q33369245 | ||
| Measuring cerebral blood flow using magnetic resonance imaging techniques | Q33691071 | ||
| Selective pharmacological inhibition of distinct nitric oxide synthase isoforms | Q34377795 | ||
| The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases | Q34440280 | ||
| Systematic review of proton magnetic resonance spectroscopy of the striatum in parkinsonian syndromes | Q34488986 | ||
| Correlation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity with blood-brain barrier monoamine oxidase activity | Q34625772 | ||
| Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease | Q35018093 | ||
| Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). | Q36503887 | ||
| Quantification of relative cerebral blood flow change by flow-sensitive alternating inversion recovery (FAIR) technique: application to functional mapping | Q36672899 | ||
| Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity | Q37597604 | ||
| Nitric oxide--the endothelium-derived relaxing factor and its role in endothelial functions | Q37820807 | ||
| Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide | Q41082551 | ||
| MPTP, MPP+ and mitochondrial function | Q41382377 | ||
| Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice. | Q41664189 | ||
| Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy | Q41847841 | ||
| Comparative toxicity of MPTP, MPP+ and 3,3-dimethyl-MPDP+ to dopaminergic neurons of the rat substantia nigra | Q42216410 | ||
| In vitro and in vivo evidences that antioxidant action contributes to the neuroprotective effects of the neuronal nitric oxide synthase and monoamine oxidase-B inhibitor, 7-nitroindazole | Q42523167 | ||
| Mapping the central effects of methylphenidate in the rat using pharmacological MRI BOLD contrast | Q43280429 | ||
| The mechanisms of neuronal death produced by mitochondrial toxin 3-nitropropionic acid: the roles of N-methyl-D-aspartate glutamate receptors and mitochondrial calcium overload. | Q44035217 | ||
| The neuronal nitric oxide synthase inhibitor 7-nitroindazole also inhibits the monoamine oxidase-B-catalyzed oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | Q45104121 | ||
| Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain | Q45256207 | ||
| Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain | Q46053255 | ||
| Slice profile effects in adiabatic inversion: application to multislice perfusion imaging | Q46197181 | ||
| Regional CBF changes in Parkinson's disease: a correlation with motor dysfunction | Q48201439 | ||
| The effects of levodopa use on diffusion coefficients in various brain regions in Parkinson's disease | Q48265517 | ||
| Energy-driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP. | Q48310314 | ||
| What is the correct value for the brain--blood partition coefficient for water? | Q48516478 | ||
| Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders | Q48586206 | ||
| Uptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP. | Q48601969 | ||
| Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase | Q48650129 | ||
| Nitric oxide synthase inhibition and MPTP-induced toxicity in the common marmoset | Q48679768 | ||
| MPP(+)-induced neurotoxicity in mouse is age-dependent: evidenced by the selective inhibition of complexes of electron transport | Q49011944 | ||
| Threshold effects and control of oxidative phosphorylation in nonsynaptic rat brain mitochondria | Q49043208 | ||
| Pharmacological magnetic resonance imaging: a new application for functional MRI. | Q51389065 | ||
| Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration. | Q51626450 | ||
| Inhibition of nitric oxide synthesis impairs autoregulation of local cerebral blood flow in the rat. | Q54245680 | ||
| Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease | Q56567926 | ||
| Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain | Q59062956 | ||
| Uptake of the neurotoxin 1-methyl-4-phenylpyridine (MPP+) by mitochondria and its relation to the inhibition of the mitochondrial oxidation of NAD+-linked substrates by MPP+ | Q69876986 | ||
| Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study | Q70192548 | ||
| Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo | Q71038834 | ||
| Inhibition of neuronal nitric oxide synthase by 7-nitroindazole: effects upon local cerebral blood flow and glucose use in the rat | Q71710210 | ||
| Half-life of nitric oxide in aqueous solutions with and without haemoglobin | Q71856450 | ||
| Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine | Q72059888 | ||
| Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity | Q72332264 | ||
| Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo | Q73760293 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacology | Q128406 |
| neurotoxicity | Q3338704 | ||
| toxic encephalopathy | Q7830379 | ||
| P304 | page(s) | 964034 | |
| P577 | publication date | 2013-08-31 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | In vivo evidence of increased nNOS activity in acute MPTP neurotoxicity: a functional pharmacological MRI study | |
| P478 | volume | 2013 |
Search more.